Merck & Co.’s new antiviral pill – once touted as a potential game changer for treating COVID-19 – is the last choice among four available options for at-risk patients given its relatively low efficacy and potential safety issues, U.S. doctors, healthcare systems and pharmacies told Reuters.
New Drug Discovery Process Could Significantly Cut Development Time
Cells, Coronavirus Cases, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Coronavirus Treatment Acceleration Program (CTAP), Drug Development, Drug Discovery, FDA, Medical Journals, Nucleoside Analogs, Papers, Science, Scientists, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), SynthesisA paper published in the journal Science on August 8 suggests that it may be possible to speed up the drug discovery process.